Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI
Clinical trial NCT04324073 · COMPLETED
Trial details
- NCT number
- NCT04324073
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-27
- Primary completion
- 2020-04-21
- Enrollment
- 239
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.